These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6382882)

  • 21. [Bacterial infections in newborn infants. Diagnostic criteria, principles of treatment, prevention].
    Aujard Y
    Rev Prat; 1991 Nov; 41(23):2375-9. PubMed ID: 1792508
    [No Abstract]   [Full Text] [Related]  

  • 22. DNA vaccines against enteric infections.
    Herrmann JE
    Vaccine; 2006 May; 24(18):3705-8. PubMed ID: 16095769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Capsular antigens of Escherichia coli K1 in cerebrospinal fluid of newborn infants without meningitis].
    Valvano MA; Grinstein S
    Medicina (B Aires); 1982; 42(1):67-73. PubMed ID: 6752631
    [No Abstract]   [Full Text] [Related]  

  • 24. [Maternal transmission of bacterial infections in 67 newborn infants (author's transl)].
    Amiel-Tison C; Pilla Grossi S; Henrion R
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(4):479-87. PubMed ID: 7005309
    [No Abstract]   [Full Text] [Related]  

  • 25. Bacterial interference for the prevention and treatment of infections.
    Falagas ME; Rafailidis PI; Makris GC
    Int J Antimicrob Agents; 2008 Jun; 31(6):518-22. PubMed ID: 18359612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of antibiotics in newborn infants following premature rupture of fetal membranes].
    Grauel EL; Weigel H; Pawlow I
    Zentralbl Gynakol; 1984; 106(11):771-3. PubMed ID: 6475388
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use.
    Schrag SJ; Hadler JL; Arnold KE; Martell-Cleary P; Reingold A; Schuchat A
    Pediatrics; 2006 Aug; 118(2):570-6. PubMed ID: 16882809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Conclusions].
    Picazo JJ
    Rev Esp Quimioter; 2007 Mar; 20(1):150-1. PubMed ID: 17530049
    [No Abstract]   [Full Text] [Related]  

  • 29. [Apropos of infection prevention in the neonatal period. Clinico-statistical studies on the use of some antibiotics].
    Fabris C; Licata D; Garzena E; Bandelloni A; Bertino E; Cavo L
    Minerva Pediatr; 1981 Feb; 33(4):143-8. PubMed ID: 7017372
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of intravenous immune globulin in newborn infants.
    Fischer GW
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):73-7. PubMed ID: 8033439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evidence of some antibacterial antibodies in human colostrum].
    Savić D; Bjelaković B; Ilić R; Kosić B; Otasević M
    Srp Arh Celok Lek; 1994; 122 Suppl 1():105-7. PubMed ID: 18173207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic strategies involving antimicrobial treatment of the gastrointestinal tract in large animals.
    Whitlock RH
    J Am Vet Med Assoc; 1984 Nov; 185(10):1210-3. PubMed ID: 6392259
    [No Abstract]   [Full Text] [Related]  

  • 33. Bacterial endocarditis in infants and children: incidence and pathogenesis.
    Siegel JD
    Pediatr Infect Dis; 1983; 2(3 Suppl):S41-4. PubMed ID: 6866799
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of virulence factor-specific egg yolk-derived immunoglobulins as a promising alternative to antibiotics for prevention of attaching and effacing Escherichia coli infections.
    Girard F; Batisson I; Martinez G; Breton C; Harel J; Fairbrother JM
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):340-50. PubMed ID: 16553806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Level of agglutinins to conditionally pathogenic enterobacteria in gastrointestinal diseases in nursing infants].
    Busygina NG; Grishchenko EM; Golyk RG; Lisnyĭ EP; Rudova AI
    Pediatr Akus Ginekol; 1978; (3):16-8. PubMed ID: 673504
    [No Abstract]   [Full Text] [Related]  

  • 36. Human colostrum contains IgA antibodies reactive to colonization factors I and II of enterotoxigenic Escherichia coli.
    Corrêa S; Palmeira P; Carneiro-Sampaio MM; Sanae Nishimura L; Guth BE
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):199-206. PubMed ID: 16831206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Heat-labile anti-enterotoxin antibodies to Escherichia coli and anti-colonization factor in human colostrum].
    Filho JM; De Castro AF; Serafim MB; Gomes AJ
    Rev Inst Med Trop Sao Paulo; 1980; 22(1):7-14. PubMed ID: 7001605
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunology of the gastrointestinal system].
    Kalden JR
    Z Rheumatol; 1987; 46 Suppl 1():10-3. PubMed ID: 3439370
    [No Abstract]   [Full Text] [Related]  

  • 39. Oral immunization: an update.
    Mestecky J; Nguyen H; Czerkinsky C; Kiyono H
    Curr Opin Gastroenterol; 2008 Nov; 24(6):713-9. PubMed ID: 19122521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of colostrum for the prevention of infection in the low birth weight infant in a developing country.
    Narayanan I; Prakash K; Verma RK; Gujral VV
    J Trop Pediatr; 1983 Aug; 29(4):197-200. PubMed ID: 6632039
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.